Consequently, STZ serves as a significant experimental paradigm for investigating the convergence of insulin resistance and Alzheimer’s-like phenotypes and pathologies and was recently found to induce a PD-like model when administered intrastriatally (Osmanovic Barilar et al. 2024). The gene discussed is INS; the disease is Parkinson disease.